Drug Type Radiopharmaceuticals and diagnostic agent |
Synonyms |
Target |
Mechanism LRRC15 inhibitors(Leucine-rich repeat-containing protein 15 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
RegulationRare Pediatric Disease (US), Orphan Drug (US) |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Osteosarcoma | Preclinical | US | 03 Sep 2024 | |
Solid tumor | Preclinical | US | 05 Aug 2024 |